GLP-1 Drugs Medications GLP-1 Agonists GLP-1 Medications Clinical Trials Semaglutide Drug Development Obesity Treatments Drugs Obesity Obesity Treatment GLP-1 Wegovy Generic Drugs Medication Ozempic Novo Nordisk Orforglipron Prescription Medications Drug Safety Injectable Drugs Counterfeit Drugs FDA Approvals Mounjaro Compounded Drugs Prescription Drugs Drug Efficacy Counterfeit Medications Diabetes Injectable Therapies Obesity Management Drug Pricing Anti-Obesity Drugs Incretin Drugs Market Trends GLP-1 Analog Drugs Diabetes Treatments Drug Delivery Systems Addiction Treatment GLP-1 Treatments Eli Lilly Drug Competition GLP Inhibitors Weight Loss Drugs Compounding GLP-1 Receptor Agonists Telehealth Consumer Health Obesity Medications Retatrutide GLP-1 Inhibitors Compounding Pharmacies Injectables Patient Experience Weight Loss Pills Injectable Medications FDA Approval Sibutramine Illicit Drugs Market Competition Tirzepatide Regulatory Issues Demand Trends Childhood Obesity Regulation
Management says a 4 GW pipeline plus a standardized 12.5 MW power block justify a $200–$275 million Torrington expansion to serve AI data center customers.
